CLINICAL_TRIALS
trial_result
· 2012-07-10
Clinical Trial Update: Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL) [Phase 2]
Summary
Phase 2 clinical trial evaluating oral miltefosine for safety and efficacy in post-kala-azar dermal leishmaniasis (PKDL) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AB Foundation | Conditions: PKDL | Phase 2 | Status: COMPLETED